Uriel Halavee
Fondateur chez Minovia Therapeutics Ltd.
Profil
Uriel Halavee was the founder of Oplon Technologies Ltd.
(1980), Oplon BV (2006), and Minovia Therapeutics Ltd.
(2012) where he held the title of Director.
He is also the founder of X Technologies, Inc., Protein Forest, Inc., Kailight Photonics, Inc., and H4 Energy Solution Ltd.
Dr. Halavee's former job was as General Manager at Soreq Nuclear Research Center.
Dr. Halavee received his undergraduate, graduate, and doctorate degrees from The Hebrew University of Jerusalem.
Postes actifs de Uriel Halavee
| Sociétés | Poste | Début |
|---|---|---|
Minovia Therapeutics Ltd.
 Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012. | Fondateur | 01/01/2012 |
Anciens postes connus de Uriel Halavee
| Sociétés | Poste | Fin |
|---|---|---|
H4 Energy Solution Ltd.
 H4 Energy Solution Ltd. Chemicals: Major DiversifiedProcess Industries H4 Energy Solution Ltd. develops apparatus and methods for improvement of photo electrolysis and fuel cells. The company was founded by Shmuel Bukshpan and Gleb Zilberstein and is headquartered in Rehovot, Israel. | Fondateur | - |
Oplon Technologies Ltd.
 Oplon Technologies Ltd. BiotechnologyHealth Technology Oplon Technologies Ltd. develops anti-bacterial materials for the healthcare, food, environmental, and industrial markets. The company was founded by Shmuel Bukshpan and Uriel Halavee in and is headquartered in Tel Aviv, Israel. | Fondateur | - |
Protein Forest, Inc.
 Protein Forest, Inc. Packaged SoftwareTechnology Services Protein Forest, Inc., a privately held company founded in 2002 and is located in Lexington, MA, is a developer and manufacturer of state-of-the-art sample fractionation technology, products, and data analysis software for mass spectrometry. The company develops, manufactures, and markets instruments, consumables, and bioinformatics software products for scientists in the life science, drug discovery, pharmaceutical, biotech, and diagnostic industries around the world. | Fondateur | - |
Kailight Photonics, Inc.
 Kailight Photonics, Inc. Telecommunications EquipmentElectronic Technology Part of Coherent Corp., Kailight Photonics, Inc. develops optical modules for the telecommunications industry. The company is based in Dallas, TX. The company was founded by Uriel Halavee, Sagie Tsadka, Shmuel Sternklar. Kailight Photonics was acquired by Optium Corp., part of Coherent Corp. from August 29, 2008 on May 17, 2007 for $40 million. | Fondateur | - |
X Technologies, Inc.
 X Technologies, Inc. Engineering & ConstructionIndustrial Services X Technologies, Inc. provides engineering service specializing in automatic test equipment. It offers information technology, information security, and program management and repair services. The firm’s products include eGent, universal flight line tester, automated motor performance set (AMPS) and universal diagnostic tester. The company was founded by Jesse Ayala in 1998 and is headquartered in San Antonio, TX. | Fondateur | - |
Formation de Uriel Halavee
| The Hebrew University of Jerusalem | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Oplon BV
 Oplon BV Industrial SpecialtiesProcess Industries Oplon BV develops antimicrobial coating technology for packaging, pads and devices. It offers protective products, coatings and processes based on a novel polymer compound, which prevent the colonization of microbes by creating a protective physical shield on surfaces. The firm’s products are used by beverages, fresh meat and dairy markets. The company was founded in 2006 by Shmuel Bukshpan and Uriel Halavee and is headquartered in Delft, the Netherlands. | Process Industries |
Soreq Nuclear Research Center
 Soreq Nuclear Research Center Miscellaneous Commercial ServicesCommercial Services Soreq Nuclear Research Center is a research and Israeli development company that specializes in various fields such as laser and electro optics, nuclear medicine, radiopharmaceutics, non-destructive testing, space components characterization and testing, crystal growth, and development of innovative radiation detectors. The company is ultimately controlled by the Government of Israel. | Commercial Services |
X Technologies, Inc.
X Technologies, Inc. Engineering & ConstructionIndustrial Services X Technologies, Inc. provides engineering service specializing in automatic test equipment. It offers information technology, information security, and program management and repair services. The firm’s products include eGent, universal flight line tester, automated motor performance set (AMPS) and universal diagnostic tester. The company was founded by Jesse Ayala in 1998 and is headquartered in San Antonio, TX. | Industrial Services |
Kailight Photonics, Inc.
Kailight Photonics, Inc. Telecommunications EquipmentElectronic Technology Part of Coherent Corp., Kailight Photonics, Inc. develops optical modules for the telecommunications industry. The company is based in Dallas, TX. The company was founded by Uriel Halavee, Sagie Tsadka, Shmuel Sternklar. Kailight Photonics was acquired by Optium Corp., part of Coherent Corp. from August 29, 2008 on May 17, 2007 for $40 million. | Electronic Technology |
Protein Forest, Inc.
Protein Forest, Inc. Packaged SoftwareTechnology Services Protein Forest, Inc., a privately held company founded in 2002 and is located in Lexington, MA, is a developer and manufacturer of state-of-the-art sample fractionation technology, products, and data analysis software for mass spectrometry. The company develops, manufactures, and markets instruments, consumables, and bioinformatics software products for scientists in the life science, drug discovery, pharmaceutical, biotech, and diagnostic industries around the world. | Technology Services |
H4 Energy Solution Ltd.
H4 Energy Solution Ltd. Chemicals: Major DiversifiedProcess Industries H4 Energy Solution Ltd. develops apparatus and methods for improvement of photo electrolysis and fuel cells. The company was founded by Shmuel Bukshpan and Gleb Zilberstein and is headquartered in Rehovot, Israel. | Process Industries |
Oplon Technologies Ltd.
Oplon Technologies Ltd. BiotechnologyHealth Technology Oplon Technologies Ltd. develops anti-bacterial materials for the healthcare, food, environmental, and industrial markets. The company was founded by Shmuel Bukshpan and Uriel Halavee in and is headquartered in Tel Aviv, Israel. | Health Technology |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012. | Health Technology |